Pharmafile Logo
Pharmafocus logo
Advanced Search

GBM

Showing 4 posts of 4 posts found.

Avastin image

Avastin gets GBM approval

June 18, 2013
Research and Development, Sales and Marketing GBM, Roche, avastin

Roche has received a major boost with the first approval in early treatment of the most aggressive form of brain …

News

Glioblastoma vaccine enters phase II

February 24, 2011
Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology

The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …

News

Vaccine for brain cancer shows promise

June 3, 2010
Research and Development Cancer, GBM, ImmunoCellular

Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …

News

Avastin approved for aggressive brain tumour

May 7, 2009
Sales and Marketing GBM, avastin

 Roche has gained US approval for Avastin in people with the aggressive brain cancer glioblastoma multiforme (GBM). The drug can …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025